SLB Stock Analysis: Schlumberger | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 79.951m USD | 12M Return: 55.6% | AN8068571086 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 504M
EPS Trend: -38.5%
Qual. Beats: 1
Rev. Trend: 76.8%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SLB N.V. (formerly Schlumberger Limited until its October 2025 renaming) is a global provider of technology and services to the energy industry, operating across the full oil and gas value chain. The company is organized into four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems, allowing it to serve customers from exploration through production and into emerging energy transition workflows such as carbon management.
Its service portfolio spans reservoir interpretation and data processing, drilling fluids and bits, directional and measurement-while-drilling technologies, hydraulic fracturing and stimulation, intervention, artificial lift, and subsea production systems, including the OneSubsea integrated offering. The oilfield services sector in which SLB operates is highly capital-intensive and cyclical, with demand tied to upstream oil and gas investment, while increasingly incorporating digitalization and lower-carbon solutions.
Founded in 1926 and headquartered in Houston, Texas, SLB is one of the largest diversified oilfield services companies globally, supplying integrated engineering support, equipment, and digital solutions to operators and energy producers worldwide.
- International rig count growth lifts reservoir performance revenue
- North American frac rebound boosts production systems margins
- Digital and integration segment scales with AI-driven exploration demand
| Net Income: 3.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.35 > 1.0 |
| NWC/Revenue: 16.99% < 20% (prev 12.45%; Δ 4.54% < -1%) |
| CFO/TA 0.12 > 3% & CFO 6.53b > Net Income 3.08b |
| Net Debt (8.73b) to EBITDA (7.15b): 1.22 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.51b) vs 12m ago 10.91% < -2% |
| Gross Margin: 16.53% > 18% (prev 20.01%; Δ -3.48% > 0.5%) |
| Asset Turnover: 69.73% > 50% (prev 72.75%; Δ -3.02% > 0%) |
| Interest Coverage Ratio: 8.57 > 6 (EBIT TTM 4.39b / Interest Expense TTM 512.0m) |
| A: 0.11 (Total Current Assets 20.2b - Total Current Liabilities 14.1b) / Total Assets 55.5b |
| B: 0.34 (Retained Earnings 18.7b / Total Assets 55.5b) |
| C: 0.08 (EBIT TTM 4.39b / Avg Total Assets 52.2b) |
| D: 0.92 (Book Value of Equity 26.1b / Total Liabilities 28.3b) |
| Altman-Z'' = 3.36 = A |
| DSRI: 1.04 (Receivables 9.13b/8.59b, Revenue 36.4b/35.5b) |
| GMI: 1.21 (GM 20.01% / 16.53%) |
| AQI: 1.06 (AQ_t 0.50 / AQ_t-1 0.47) |
| SGI: 1.03 (Revenue 36.4b / 35.5b) |
| TATA: -0.06 (NI 3.08b - CFO 6.53b) / TA 55.5b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of August 25, 2026, the stock is trading at USD 54.00 with a total of 14,020,584 shares traded. Over the past week, the price has changed by +0.26%, over one month by +3.01%, over three months by -6.38% and over the past year by +55.61%.
Current recommended Stop Loss: 52.10 (which is 3.5% or 1.3 ATR below the current price).
Schlumberger has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy SLB.
- StrongBuy: 17
- Buy: 9
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 61.9 | 14.7% |
P/E Trailing = 26.2781
P/E Forward = 21.1864
P/S = 2.1985
P/B = 3.0478
P/EG = 1.8283
Revenue TTM = 36.4b USD
EBIT TTM = 4.39b USD
EBITDA TTM = 7.15b USD
Long Term Debt = 11.1b USD (from longTermDebt, last quarter)
Short Term Debt = 1.66b USD (from shortTermDebt, last quarter)
Debt = 12.8b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.73b USD (calculated: Debt 12.8b - CCE 4.07b)
Enterprise Value = 88.7b USD (80.0b + Debt 12.8b - CCE 4.07b)
Interest Coverage Ratio = 8.57 (Ebit TTM 4.39b / Interest Expense TTM 512.0m)
EV/FCF = 19.47x (Enterprise Value 88.7b / FCF TTM 4.55b)
FCF Yield = 5.14% (FCF TTM 4.55b / Enterprise Value 88.7b)
FCF Margin = 12.52% (FCF TTM 4.55b / Revenue TTM 36.4b)
Net Margin = 8.46% (Net Income TTM 3.08b / Revenue TTM 36.4b)
Gross Margin = 16.53% ((Revenue TTM 36.4b - Cost of Revenue TTM 30.4b) / Revenue TTM)
Gross Margin QoQ = 15.55% (prev 15.26%)
Tobins Q-Ratio = 1.60 (Enterprise Value 88.7b / Total Assets 55.5b)
Interest Expense / Debt = 4.00% (Interest Expense 512.0m / Debt 12.8b)
Taxrate = 18.99% (744.0m / 3.92b)
NOPAT = 3.55b (EBIT 4.39b * (1 - 18.99%))
Current Ratio = 1.44 (Total Current Assets 20.2b / Total Current Liabilities 14.1b)
Debt / Equity = 0.49 (Debt 12.8b / totalStockholderEquity, last quarter 26.1b)
Debt / EBITDA = 1.22 (Net Debt 8.73b / EBITDA 7.15b)
Debt / FCF = 1.92 (Net Debt 8.73b / FCF TTM 4.55b)
Total Stockholder Equity = 26.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.90% (Net Income 3.08b / Total Assets 55.5b)
RoE = 11.84% (Net Income TTM 3.08b / Total Stockholder Equity 26.0b)
RoCE = 11.81% (EBIT 4.39b / Capital Employed (Equity 26.0b + L.T.Debt 11.1b))
RoIC = 8.60% (NOPAT 3.55b / Invested Capital 41.3b)
WACC = 8.02% (E(80.0b)/V(92.7b) * Re(8.79%) + D(12.8b)/V(92.7b) * Rd(4.00%) * (1-Tc(0.19)))
Discount Rate = 8.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 54.81 | Cagr: 2.06%
[DCF] Terminal Value 75.14% ; FCFF base≈4.59b ; Y1≈4.53b ; Y5≈4.62b
[DCF] Fair Price = 42.77 (EV 72.2b - Net Debt 8.73b = Equity 63.5b / Shares 1.48b; r=8.35% [WACC [floored]]; 5y FCF grow -2.19% → 2.50% )
EPS Correlation: -38.50 | EPS CAGR: -3.86% | SUE: 2.66 | # QB: 1
Revenue Correlation: 76.79 | Revenue CAGR: 3.44% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.62 | Chg30d=-3.51% | Revisions=-55% | Analysts=21
EPS current Year (2026-12-31): EPS=2.50 | Chg30d=-1.15% | Revisions=-38% | GrowthEPS=-14.7% | GrowthRev=+3.7%
EPS next Year (2027-12-31): EPS=3.23 | Chg30d=-1.77% | Revisions=-38% | GrowthEPS=+29.3% | GrowthRev=+7.6%
[Analyst] Revisions Ratio: -47% (up=15, down=44)